Muhlenhoff M. , Eckhardt M., Bethe A., Frosch M., Gerardy-Schahan R.Polysialylation of NCAM by a single enzyme. Curr Biol1966;6:1188-1191.
2.
Rutishauser U., Landmesser L.Polysialic acid in the vertebrate nervous system: a promoter of plasticity in cell-cell interactions. Trends Neurosci1996;19.422-427.
3.
Poltorak M., Frey MA, Wnght R., et al Increased neural cell adhesion molecule in the CSF of patients with mood disorder. J Neurochem1966;66:1532-1538.
4.
Poltorak M., Khoja I., Hemperly JJ, et al. Disturbances in cell recognition molecules (N-CAM and L1 antigen) in the CSF of patients with schizophrenia. Exp Neurol1995;131:266-272.
5.
Mahadik SP, Mukherjee S., Wakade CG, Laev H., Reddy RR, Schnur DBDecreased adhesiveness and altered cellular distribution of fibronectin in fibroblasts from schizophrenic patients. Psychiatry Res1994;53:878-897.
6.
Fields RD, Itoh I.Neural cell adhesion molecules in activity-dependent development and synaptic plasticity. Trends Neurosci1996,19:473-480
7.
Muller D., Wang C., Skibo G., et al PSA-NCAM is required for activity-induced synaptic plasticity . Neuron1996; 17:413-422.
8.
Becker CG, Artola A., Gerardy-Schahn R., Becker T., Wezl H., Schachner M.The polysialic acid modification of the neural cell adhesion molecule is involved in spatial learning and hippocampal long-term potentiation. J Neurosci Res1996;45. 143-152.
9.
Barbeau D., Liang JJ, Robitalille Y., Quirion R., Snvastava LKDecreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci U S A1995;92:2785-2789.
10.
Faissner A. , Krus J., Nieke J., Schachner M.Expression of neural cell adhesion molecule L1 during development in neurological mutants and in the peripheral nervous system. Dev Brain Res1984;15:69-82.
11.
Djabali M., Mattei MG, Roux D., et al. The human L1 adhesion molecule is encoded by an HTF-associated gene located in Xq28. Cytogenet Cell Genet1989;51:991.
12.
Fransen E., Vits L., Van Camp G., Willems PGThe clinical spectrum of mutations in L1, a neuronal cell adhesion molecule . Am J Med Genet1996;64:73-77.
13.
Uyemura K., Takeda Y., Asou H., Hayasaka K.Neural cell adhesion proteins and neurological diseases. J Biochem (Tokyo) 1994;116:1187-1192.
14.
Kenwrick S., Jouet M., Donnai D X-linked hydrocephalus and MASA syndrome. J Med Genet1996;33:59-65.
15.
Fransen E., Lemmon V., Van Camp G., Vits L., Coucke P., Willems PJCRASH syndrome : climcal spectrum of corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraparesis and hydrocephalus due to mutations in one single gene, L1. Eur J Hum Genet1995;3:273-284
16.
Menkes JH, Philippart M., Clark DBHereditary partial agenesis of corpus callosum. Arch Neurol1964; 11: 198-208.
17.
Kaplan P.X-linked recessive inheritance of agenesis of the corpus callosum. J Med Genet1983;20:122-124.
18.
Kang W-M., Huang C-C., Lin S-J.X-linked recessive inheritance of dysgenesis of corpus callosum in a Chinese family. Am J Med Genet1992;44:619-623.
19.
Jouet M., Rosenthal A., Armstrong G., et al X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene. Nat Genet1994;7:402-407.
20.
Kobayashi H. , Garcia CA, Alfonso G., Marks HG, Hoffman EPMolecular genetics of familial spastic paraplegia: a multitude of responsible genes. J Neurol Sci1996;137:131-138.
21.
Burton BKRecurrence risk for congenital hydrocephalus. Clin Genet1979;16: 47-53.
22.
Rosenthal A. , Joulet M., Kenwnck S.Aberrant splicing of neural cell adhesion molecule L1 mRNA in a family with X-linked hydrocephalus. Nat Genet1992;2: 107-112.
23.
Grondona JM , Perez-Martm M., Cifuentes M., et al. Ependymal denudation, aqueductal obliteration and hydrocephalus after a single injection of neuraminidase into the lateral ventricle of adult rats. J Neuropathol Exp Neurol1996;55:999-1008.
24.
Willems PJ, Brouwer OF, Dijkstra I., Wilmink J.X-linked hydrocephalus. Am J Med Genet1987 ;27:921-928
25.
Landrieu P. , Nmane J., Ferrier G., Lyon G.Aqueductal stenosis in X-linked hydrocephalus. a secondary phenomenon? Dev Med Child Neurol1979;21:637-642.
26.
Ramanathan R., Wilkemeyer MF, Mittal B., Pendwes G., Charness MEAlcohol m-hibits cell-cell adhesion mediated by human L1. J Cell Biol1996;133:381-390.
27.
Wood PM, Schachner M., Bunge RPInhibition of Schwann cell myelination in vitro by antibody to the L1 adhesion molecule. J Neurosci1990;10:3635-3645.
28.
Lemke G., Lamar E., Patterson J.Isolation and analysis of the gene encoding peripheral myelin protein zero . Neuron1988;1: 73-78.
29.
Lmmgton C., Webb M., Woodhams P.A novel myelin associated glycoprotein defined by a mouse monoclonal antibody . J Neuroimmunol1984;6:387-396.
30.
Quarles RHGlycoprotems of myelin sheath. J Mol Neurosci1997;81:1-12.
31.
Uyemura K., Kitamura K., Miura M.Structure and molecular biology of P0 glycoprotem. In: Martenson RE, editor. Myelin: chemistry and biology. Boca Raton: CRC; 1992. p. 481-508.
32.
Choe S.Packing of myelin protein zero. Neuron1996 ;17:363-365
33.
Giese KP, Martini R., Lemke G., Sonano P., Schachner M.Mouse PO gene disruption leads to hypomyelinarion, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell1992;71:565-576.
34.
Warner LE, Hilz MJ, Appel SH, et al. Clinical phenotypes of different MPZ (PO) mutations may include Charcot-Mane Tooth type 1B, Dejenne-Sottas, and congenital hypomyelination . Neuron1996;17:451-460.
35.
Brunner D., Lassmann H., Waehneldt TV, Matthieu JM, Linington C.Differential ultrastructural localization of myelin basis protein, myelin/oligodendroglial glycoprotem, and 2',3'-cyclic nucleotide 3'phosphodiesterase in the CNS of adult rats. J Neurochem1989;52:296-304.
36.
Adelmann M. , Wood J., Benzel I., et al. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol1995;63:17-27.
37.
Mendel I., Kerlero de Rosbo N., Ben-Nun A.A myelin ohgodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogemc T cells. Eur J Immunol1995;25: 1951-1959.
38.
Johns TG, Kerlero de Rosbo N., et al. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol1995;154:5536-5541.
39.
Bartoszewicz ZP, Noronha NB, Fujita N., et al. Abnormal expression and glycosylation of the large and small isoforms of myelin-associated glycoprotein in dysmyelinating trembler mutants. J Neurosci Res1995;41:27-38.
40.
Gabriel JM, Erne B., Miescher GC, et al Selective loss of myelin-associated glycoprotein from myelin correlates with anti-MAG antibody titer in demyelinating paraproteinaemic polyneuropathy. Brain1996;119:775-787.
41.
Quarles R., Colman D., Salzer J., Trapp B.Myelin-associated glycoprotem: structure-function relationships and involvement in neurological diseases. In: Martenson R , editor. Myelin: biology and chemistry. Boca Raton: CRC; 1992. p. 4413-4448.
42.
Tatum AHExperimental paraprotem neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotem. Ann Neurol1993;33:502-506.
43.
Probstmeier R., Fahrig T., Spiess E., Schachner M.Interactions of the neural cell adhesion molecule and myelin-associated glycoprotein with collagen type I: involvement in fibnllogenesis . J Cell Biol1992;116:1063-1070.
44.
Mukhopadhyay G., Doherty P., Walsh FS, Crocker PR, Filbm MTA novel role for myelin-associated glycoprotein as an m-hibitor of axonal regeneration. Neuron1994;13:757-767
45.
McKerracher L., David S., Jackson DL, Kottis V., Dunn RJ, Braun PEIdentification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neunte growth. Neuron1994;13:805-811.
46.
Li M., Shibeta A., Li C., et al. Myelin-associated glycoprotem inhibits neunte/ axon growth and causes growth cone collapse. J Neurosci Res1996;46:404-414.
47.
Bartsch U.Myelination and axonal regeneration in the central nervous system of mice deficient in myelin-associated glycoprotem. J Neurocytol1996;25:303-313.
48.
Riehl R., Johnson K., Bradley R., et al. Cadhenn function is required for axon outgrowth in retinal ganglion cells in vivo. Neuron1996;17:837-848.
49.
Cifuentes-Diaz C., Nicolet M., Goudou D., Rieger F., Mege RMN-cadherin expression in developing adult and denervatmg chicken neuromuscular system: accumulations at both the neuromuscular junction and the node of Ranvier. Development1994;120:1-11.
50.
Beesley PW, Mummery R., Tibaldi J.N-cadherin is a major glycoprotem component of isolated rat forebram postsynaptic densities. J Neurochem1995;64:2288-2294.
51.
Yamagata M. , Herman JP, Sanes JRLamina-specific expression of adhesion molecules in developing chick optic tectum. J Neurosci1995;15:4556-4571.
52.
Uchida N., Honjo Y., Johnson KR, Wheelock JM, Takeichi M.The catenin/ cadhenn adhesion system is localized in synaptic junctions bordering transmitter release zones. J Cell Biol1996 ,135:767-779.
53.
Fannon AM, Colman DRA model for central synaptic junctional complex formation based on the differential adhesive specificities of cadhenns. Neuron1996; 17:423-434.
54.
DeSilva U., D'Arcangelo G., Braden VV, et al. The human reelin gene: isolation, sequencing and mapping on chromosome 7Genome Res1997;2:157-164.
55.
D'Arcangelo G., Miao GG, Chen SC, Soares HD, Morgan JI, Curran T.A protem related to extracellular matrix protems deleted in the mouse mutant reeler. Nature1995;374:719-723.
56.
Rose LM, Richards TL, Peterson J., Petersen R., Alvord EC Jr.Resolution of CNS lesions following treatment of experimental allergic encephalomyelitis in macaques with monoclonal antibody to the CD18 leukocyte integrin. Mult Scler1997;2:259-266.
57.
Kent SJ, Karlik SJ, Cannon C., et al. A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J Neuroimmunol1995;58:1-10.
58.
Matsumota A., Enomoto T., Fujiwara Y., Baba H., Matsumoto R Enhanced aggregation of beta-amyloid-containing peptides by extracellular matrix and their degradation by the 68 kDa senne protease prepared from human brain. Neurosci Lett1996;220:159-162.
59.
Storey E., Spurck T., Pickett-Heaps J., Beyreuther K., Masters CLThe amyloid precursor protein of Alzheimer's disease is found on the surface of static but not activity motile portions of neurites. Brain Res1996;735:59-66.
60.
Yamazaki T. , Koo EH, Selkoe DJCell surface amyloid beta-protem precursor colocalizes with beta 1 integnns at substrate contact sites in neural cells . J Neurosci1997;17:1004-1010
61.
Muir D., Johnson J., Rojiani M., Inglis BA, Rojiani A., Mana BLAssesment of lammm-mediated glioma invasion in vitro and by glioma tumors engrafted with rat spinal cord. J Neurooncol1996;30:199-211.
62.
Soussi-Yanicostas H., Hardelin JP, Arroyo-Jimenez MM, et al. Initial charactenzation of anosmin-1, a putative extracellular matrix protein synthesized by definite neuronal cell populations in the central nervous system. J Cell Sci1996;109.1749-1757.
Matsumura K. , Yamada H., Saito F., Sunada Y., Shimizu T.Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse. Neuromuscul Disord1997;7:7-12.
65.
Martin PT, Kaufinan SJ, Kramer RH, Sanes JRSynaptic integnns in developing, adult, and mutant muscle: selective association of alpha 1, alpha 7A, and alpha 7B integnns with the neuromuscular junction . Dev Biol1996;174:125-139.
66.
Einheber S. , Schnapp LM, Salzer JL, Cappiello ZB, Milner TARegional and ultrastructural distribution of the alpha 8 integnn subunit in developing and adult rat brain suggests a role in synaptic function. J Comp Neurol1996;370:105-134.
67.
Bahr BA, Staubli U., Xiao P., et al. Arg-Gly-Asp-Ser-selective adhesion and the stabilization of long-term potentiation: pharmacological studies and the characterization of a candidate matrix receptorJ Neurosci1997 ;17:1320-1329.
68.
Devaux B., Enderlin F., Wallner B., Smilek DEInduction of EAE in mice with recombinant human MOG, and treatment of EAE with MOG peptide. J Neuroimmunol1997;75:169-173.
69.
Bregman BS, Kunkel-Bagden E., Schnell L., Dia HN, Gao D., Schwab MERecovery from spinal cord injury mediated by antibody to neunte growth inhibitors . Nature1995;378:498-501.
70.
Kobayashi S. , Miura M., Asou H., Inoue HK, Ohye C., Uyemura K.Grafts of genetically modified fibroblasts expressing neural cell adhesion molecule L1 into transected spinal cord of adult rats. Neurosci Lett1995;188:191-194.